Consun Pharmaceutical Group Limited (Consun Pharma) disclosed a share buyback completed on 21 May 2026, purchasing 102,000 ordinary shares on the Hong Kong Stock Exchange.

• Transaction details – Buy-back volume: 102,000 shares – Price range: HK$14.37–HK$14.47 per share – Volume-weighted average price: HK$14.44 per share – Aggregate consideration: HK$1.47 million

• Capital structure after the transaction (21 May 2026) – Issued shares (excluding treasury): 841.40 million – Treasury shares: 152,000 – Total issued shares (including treasury): 841.55 million

• Repurchase mandate utilisation – Authorised under mandate dated 22 May 2025: 85.13 million shares – Cumulative shares bought back under the mandate: 13.83 million shares, representing 16.25 % of the issued shares at the mandate date – Moratorium on new share issues or treasury-share sales: in force until 20 June 2026

All repurchased shares from this transaction are being retained as treasury shares; none have been cancelled. The company confirmed that the repurchase complied with Hong Kong listing rules and all applicable regulatory requirements.